Greater incidence of depression with hypnotic use than with placebo - Test2 - elhamkhani - TriplyDB

Greater incidence of depression with hypnotic use than with placebo

Greater incidence of depression with hypnotic use than with placebo

http://www.wikidata.org/entity/Q21260274

about

sameAs

Who should sponsor sleep disorders pharmaceutical trials?Magic bullets for insomnia? Patients' use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit Use of Sleep Medications and Mortality: The Hordaland Health Study Effectiveness and cost-effectiveness of an educational intervention for practice teams to deliver problem focused therapy for insomnia: rationale and design of a pilot cluster randomised trial.Advances in the management of insomnia 'Doing the right thing': factors influencing GP prescribing of antidepressants and prescribed doses Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study Hippocampal adult neurogenesis is enhanced by chronic eszopiclone treatment in rats.What is Behind the Seeming Cessation of the Increase in Sleep Medicine Consumption in Finland During the Last Years?Hypnotics' association with mortality or cancer: a matched cohort study.Mortality hazard associated with anxiolytic and hypnotic drug use in the National Population Health Survey.Insomnia and daytime sleepiness are risk factors for depressive symptoms in the elderly.Patient factors associated with SSRI dose for depression treatment in general practice: a primary care cross sectional study.Risk of psychiatric disorders in patients with chronic insomnia and sedative-hypnotic prescription: a nationwide population-based follow-up study.The association between insomnia and cardiovascular diseases Benzodiazepine and z-hypnotic prescribing for older people in primary care: a cross-sectional population-based study.Eszopiclone and fluoxetine enhance the survival of newborn neurons in the adult rat hippocampus Which symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy?The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.Mortality Risk of Hypnotics: Strengths and Limits of Evidence.Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population-Based Case-Control Study in Taiwan.What do hypnotics cost hospitals and healthcare?Is suvorexant a better choice than alternative hypnotics?Association between hypnotics use and increased mortality: causation or confounding?The effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: comparison with diazepam.Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages.

P2860

Q24641841-895B31D2-C539-468D-8F80-6C78ECA8DA3B Q24642656-124D12AD-C99C-4D76-BA3D-FB19067D71F3 Q26745934-8BF834E3-7594-4B5A-8548-70D21F4DF692 Q28833208-0D088478-BEEC-4D2A-B34C-129C4576B99C Q33403104-E4264628-3BB7-4C4C-8F3B-2718F8FD4FD6 Q33720437-DA7BDAC0-B2B8-408C-9059-F99B6EBE19AA Q33808307-ABA6382A-4A84-4BBA-BBCE-11426E0D9705 Q34040228-56661FD1-1790-46C2-8312-439E03527C93 Q34061181-8662E0EB-1F09-4E63-B0FC-2AC717E33867 Q34074150-3B6565FE-BED7-4742-8D61-2CB566F17FA2 Q34257362-AFDDED93-9E77-4A4B-B16A-65418703C962 Q34623459-61714A5D-7632-462A-A827-6B0372C2034B Q35110572-3E0F8FAE-6972-4182-9B92-6E6AD9699132 Q35124705-5DD870B7-04D4-4BE7-8CE6-A9FBA9319FA1 Q35542038-7022F715-3B81-42AC-B22B-6EA3457F3BFD Q36779786-CD0F6C89-7DEA-4588-9095-15B0516FFD1D Q36912629-5420B489-7E9F-4CB9-8B21-BFFC7CDCAF7A Q36914926-7572110F-D17B-4285-B5E5-6665B134335A Q37250950-C28E200C-4806-41D4-A52A-2E94D9CDE601 Q38190472-EC9407D9-D28B-491F-91D7-F639CB65BAD2 Q38631980-0780F1FE-CE4C-4747-BDB0-D130CBC3A41E Q39475552-8C62C50E-68A7-4871-B763-FB0939C516F5 Q40092020-6FFEC70D-C445-45B7-9263-FC64E2C02170 Q40900071-5A3B5927-EABB-4B21-9B02-EEC682B08CCA Q41111610-6FF9B3CB-DC5B-4AD2-863F-2FB13DA9A477 Q47798865-32713719-FD5D-4EC7-9742-4345B68FA3BD Q48268388-3FD56738-685C-4624-8CD2-11C92002BF65

P2860

Greater incidence of depression with hypnotic use than with placebo

http://www.wikidata.org/entity/Q21260274

description

2007 nî lūn-bûn

@nan

2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Greater incidence of depression with hypnotic use than with placebo

@ast

Greater incidence of depression with hypnotic use than with placebo

@en

Greater incidence of depression with hypnotic use than with placebo

@en-gb

Greater incidence of depression with hypnotic use than with placebo

@nl

type

label

Greater incidence of depression with hypnotic use than with placebo

@ast

Greater incidence of depression with hypnotic use than with placebo

@en

Greater incidence of depression with hypnotic use than with placebo

@en-gb

Greater incidence of depression with hypnotic use than with placebo

@nl

prefLabel

Greater incidence of depression with hypnotic use than with placebo

@ast

Greater incidence of depression with hypnotic use than with placebo

@en

Greater incidence of depression with hypnotic use than with placebo

@en-gb

Greater incidence of depression with hypnotic use than with placebo

@nl

P1433

Q21260274-3F9176BE-8889-4269-9C78-21012737E0D7

P1476

Q21260274-B3FB2863-2CD7-41D8-B938-129113246DBF

P2093

Q21260274-B8FFA769-6BE3-418B-8E19-FEB1CBC4ABEC

P2860

Q21260274-14EF25DD-3039-4422-A963-F33AE1C60150

Q21260274-153A8EF0-0EF6-428B-8143-F072DB5EFD82

Q21260274-2046637A-CCCA-4467-9ABB-EB440545A5FD

Q21260274-2AC98293-F1DC-4E00-B2A0-F0D1B8A53832

Q21260274-367464C5-E59D-467A-AEC5-891ED77AC946

Q21260274-6FB5E9F5-4ED4-45A2-A10E-40558234971B

Q21260274-6FCA87E9-0B53-45D7-98EE-91C763B8D286

Q21260274-74DEA3C8-42CB-401F-A2B3-91D27624D62C

Q21260274-829B2E9E-A488-4203-AD47-FA434DF5DFA3

Q21260274-89FD1A61-74B8-4D6F-A484-F6CB19C4A825

P2888

Q21260274-32186AA7-8235-469C-A79A-F1C529567983

P304

Q21260274-73E20FEF-4342-4F80-9645-054BE73E8DC5

P31

Q21260274-3EA4C549-0D30-4928-9A59-44D67301E359

P3181

Q21260274-89CD13F1-6C67-45A6-AF33-3DCBB59F5872

P356

Q21260274-70538E5E-465D-4838-AB79-0BC32A7E397C

P407

Q21260274-247EA52B-1791-4327-8BF8-D7390F4C1B18

P433

Q21260274-6CE51271-4436-4F36-990E-F4512B87DDAA

P478

Q21260274-5B024FBF-C451-4708-A4DF-D633FE7A26A0

P577

Q21260274-2E1547D0-D638-4E88-94F8-B076E0E2DB4B

Q21260274-890F2E52-731B-4DB2-A21E-5550EFB3C7C0

P5875

Q21260274-9094A139-9A4A-4AC6-8818-C340FF547DC1

P6179

Q21260274-DEDFFD94-782B-413E-9453-3F9C90636000

P698

Q21260274-20A81E3D-7033-4A70-BB02-2F5ADEFA3F8C

P921

Q21260274-6AC37CA2-2478-4ABB-B256-891AA5D1D5F7

P932

Q21260274-8423725E-10D8-43A2-8EEF-0FE1005AFC09

P3181

P356

P1433

P1476

Greater incidence of depression with hypnotic use than with placebo

@en

P2093

Daniel F Kripke

http://www.w3.org/2001/XMLSchema#string

P2860

Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial

Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison

Sleep deprivation in depression: what do we know, where do we go?

Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.

Psychological treatment for insomnia in the regulation of long-term hypnotic drug use.

Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults.

Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?

Psychological and behavioral treatment of insomnia:update of the recent evidence (1998-2004).

The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs.

Chronic insomnia as a risk factor for developing anxiety and depression

P2888

P304

42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1485726

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1471-244X-7-42

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2007-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6127549

http://www.w3.org/2001/XMLSchema#string

P6179

1028981161

http://www.w3.org/2001/XMLSchema#string

P698

17711589

http://www.w3.org/2001/XMLSchema#string

P921

P932

1994947

http://www.w3.org/2001/XMLSchema#string